rs2071190

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000545.8(HNF1A):​c.527-51T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 1,571,250 control chromosomes in the GnomAD database, including 47,407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4847 hom., cov: 32)
Exomes 𝑓: 0.24 ( 42560 hom. )

Consequence

HNF1A
NM_000545.8 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.613

Publications

29 publications found
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
HNF1A Gene-Disease associations (from GenCC):
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • type 1 diabetes mellitus 20
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hyperinsulinism due to HNF1A deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonpapillary renal cell carcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-120993469-T-A is Benign according to our data. Variant chr12-120993469-T-A is described in ClinVar as Benign. ClinVar VariationId is 674357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF1ANM_000545.8 linkc.527-51T>A intron_variant Intron 2 of 9 ENST00000257555.11 NP_000536.6
HNF1ANM_001306179.2 linkc.527-51T>A intron_variant Intron 2 of 9 NP_001293108.2
HNF1ANM_001406915.1 linkc.527-51T>A intron_variant Intron 2 of 8 NP_001393844.1
HNF1AXM_024449168.2 linkc.527-51T>A intron_variant Intron 2 of 8 XP_024304936.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF1AENST00000257555.11 linkc.527-51T>A intron_variant Intron 2 of 9 1 NM_000545.8 ENSP00000257555.5

Frequencies

GnomAD3 genomes
AF:
0.245
AC:
37253
AN:
151920
Hom.:
4829
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.275
Gnomad AMR
AF:
0.329
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.182
Gnomad FIN
AF:
0.197
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.242
Gnomad OTH
AF:
0.241
GnomAD2 exomes
AF:
0.244
AC:
59588
AN:
243864
AF XY:
0.234
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.407
Gnomad ASJ exome
AF:
0.137
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.198
Gnomad NFE exome
AF:
0.236
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.240
AC:
341185
AN:
1419214
Hom.:
42560
Cov.:
25
AF XY:
0.236
AC XY:
167246
AN XY:
707948
show subpopulations
African (AFR)
AF:
0.240
AC:
7802
AN:
32530
American (AMR)
AF:
0.392
AC:
17184
AN:
43808
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
3512
AN:
25840
East Asian (EAS)
AF:
0.193
AC:
7633
AN:
39470
South Asian (SAS)
AF:
0.166
AC:
14133
AN:
85054
European-Finnish (FIN)
AF:
0.207
AC:
10855
AN:
52514
Middle Eastern (MID)
AF:
0.107
AC:
539
AN:
5016
European-Non Finnish (NFE)
AF:
0.247
AC:
266148
AN:
1076094
Other (OTH)
AF:
0.227
AC:
13379
AN:
58888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
13463
26927
40390
53854
67317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9126
18252
27378
36504
45630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
37314
AN:
152036
Hom.:
4847
Cov.:
32
AF XY:
0.243
AC XY:
18066
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.248
AC:
10295
AN:
41454
American (AMR)
AF:
0.331
AC:
5051
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
479
AN:
3468
East Asian (EAS)
AF:
0.246
AC:
1273
AN:
5172
South Asian (SAS)
AF:
0.183
AC:
884
AN:
4818
European-Finnish (FIN)
AF:
0.197
AC:
2087
AN:
10576
Middle Eastern (MID)
AF:
0.127
AC:
37
AN:
292
European-Non Finnish (NFE)
AF:
0.242
AC:
16458
AN:
67958
Other (OTH)
AF:
0.237
AC:
499
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1443
2886
4329
5772
7215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.219
Hom.:
700
Bravo
AF:
0.258
Asia WGS
AF:
0.244
AC:
848
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.040
DANN
Benign
0.61
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071190; hg19: chr12-121431272; COSMIC: COSV57463204; COSMIC: COSV57463204; API